Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Mahmmod S, Schultheiss JPD, van Bodegraven AA, Dijkstra G, et al. Outcome of Reverse Switching From CT-P13 to Originator Infliximab in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2021 Feb 4. pii: 6128461. doi: 10.1093.
PMID: 33538298


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016